Maryam, Samina published the artcileStudy to determine the clinical effectiveness of nitazoxanide in treatment of giardiasis among children, SDS of cas: 55981-09-4, the main research area is Giardia giardiasis diarrhea nitazoxanide.
Giardia lambia intestinal infection is a common cause of diarrhea not only in Pakistan but around the world. It is believed to be a significant cause of morbidity and mortality in the pediatric age group. Aim: The aim of the study was to test the effectiveness of Nitazoxanide treatment in children with diarrhea caused by G. lambia. Methods: A total of 50 children with diarrhea caused by G. intestinalis received a 3-day nitazoxanide therapy (10 mg / kg / day in 2 doses for 3 days). Patients were monitored for clin. response 7 days after initiation of treatment, and then a stool sample was collected for parasitol. and lamblia antigen testing. Results: Diarrhea resolved in all 50 (100%) children treated with nitazoxanide prior to the 7-day follow-up visit. Most diarrhea resolved within 4 days. The Giardia antigen turned neg. in 96.0% of the population after 3 days of treatment. Whereas the giardia and / or oocytes / cysts became neg. in 86.0% of the patient population. Conclusions: The 3-day cycle of nitazoxanide suspension is as effective as the treatment of lamblia in children. It is well tolerated and has no significant side effects.
Indo American Journal of Pharmaceutical Sciences published new progress about Antigens Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 55981-09-4 belongs to class esters-buliding-blocks, name is 2-((5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate, and the molecular formula is C12H9N3O5S, SDS of cas: 55981-09-4.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics